
John Weidenbruch has served as the executive
vice president and general counsel at Idenix since September 2006. Prior to
joining Idenix, Weidenbruch served as general counsel at Abraxis BioScience
Inc., where he was responsible for all legal aspects of the company, including
regulatory, corporate and commercialization activities. Prior to joining
Abraxis, Weidenbruch worked at Amgen Inc. for more than ten years where he held
positions of increasing responsibility including senior director of law
operations and senior associate general counsel of global commercial
operations, leading a team of attorneys that, along with day-to-day guidance
for commercial activities, supported the launch of new products. Weidenbruch
also served as the assistant general counsel and director of state government
relations for the Nonprescription Drug Manufacturers Association where he
directed the association’s legislative representation before all fifty state
legislatures, boards of pharmacy and regulatory bodies
Weidenbruch holds a B.A. from Loyola College in Baltimore, Maryland and a J.D. from Georgetown University Law Center in Washington, D.C.